The Centers for Medicare and Medicare Services is rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable and Necessary” (MCIT/R&N) final rule because of concerns that the provisions in the final rule may not have been sufficient to protect Medicare patients.
Read More
CMS published the CY 2022 Medicare Physician Fee Schedule Final Rule, which includes the final policies for the 2022 performance year of the Quality Payment Program. The rule affects traditional MIPS, MIPS Value Pathways, the APM Performance Pathway, Advanced APMs, and the Medicare Shared Savings Program.
The Centers for Medicare & Medicaid Services has extended two deadlines affecting eligible hospitals and critical access hospitals participating in the Hospital Inpatient Quality Reporting Program and/or the Medicare Promoting Interoperability Program.
The CMS Innovation Center is pleased to release a white paper detailing the vision for the Center over the next 10 years titled, “Driving Health System Transformation – A Strategy for the CMS Innovation Center’s Second Decade.”
By Devin Partida – Health care payments have undergone a tumultuous period in the past two years. Amid the COVID-19 pandemic, CMS has adjusted multiple policies and implemented several new ones. These changes that seek to improve patient care and accessibility have considerable impacts on health care professionals.
CAHs and EHs are required to participate in the Medicare Promoting Interoperability Program to successfully demonstrate meaningful use of certified EHR technology during the applicable reporting period to avoid a downward payment adjustment for a CAH or EH applicable payment year.
The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of September that we think deserve sharing again.
The Sequoia Project, a non-profit dedicated to solving health IT interoperability challenges for the public good, has launched a special edition of its popular information blocking compliance boot camp program, targeted for health plans and payers.
By Dr. Lee A. Fleisher – CMS is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N).